Form 4 for TXG 10x Genomics, Inc.
Accepted 2024-03-18 00:00:00 ET · period of report 2024-03-14 · accession 0001610717-24-000163 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-18 | 2024-03-14 | TXG | Saxonov Serge | CEO, Dir | G - Gift | $0.00 | -1,086 | 805.7K | -0.1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-03-14 | G | D | 1,086 | $0.00 | 805,664 | D | — | — | (F1) Reflects transfer of 29,900 shares to Y/S Descendants' Trust and 6,250 shares to Y/S Pot Trust on March 14, 2024. |